Four new data presentations, including late breaking clinical study data, underscores the value of KidneyIntelX testing in helping slow progression of chronic kidney disease in type 2 diabetes patientsLONDON and SALT LAKE CITY, June 15, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that three scientific abstracts have been accepted at the upcoming American Diabetes Association 83rd Scientific Sessions (June 23-26, 2023) in San Diego, California and another abs
Related Keywords
United States , San Diego , California , University Of Illinois , Illinois , London , City Of , United Kingdom , New Orleans , Louisiana , Chicago , American , Joji Tokita , Karla Gonye , Kibum Kim , Ignacio Guerrero Ros , Girish Nadkarni , Scientific Sessions Of The American Diabetes Association , Drug Administration , York State Department Of Health , Division Of Data , American Diabetes Association , Centers For Disease , Exchange Commission , Professor Department Of Pharmacy Systems , Diabetic Kidney Disease In Veterans Health Administration , American Association Of Nurse Practitioners National Conference , Nasdaq , American Association Of Nurse Practitioner , Mount Sinai Health System , Large Integrated Health Care System , Charles Bronfman Institute Of Personalized Medicine System , Scientific Sessions , American Association , Nurse Practitioners National Conference , Diabetes Association , Risk Profiling , Large Integrated Health Care , Diabetic Kidney , Charles Bronfman Institute , Personalized Medicine System Chief , Digital Medicine , Arthur Fishberg Professor , Monday June , Diabetic Kidney Disease , Veterans Health , Assistant Professor Department , Pharmacy Systems , Sunday June , Nurse Practitioner , Patient Receptivity Towards Receipt , Prognostic Risk Score , Patient Care Navigation Team , Disease Control , Breakthrough Device Designation , New York State Department , Mount Sinai , Private Securities Litigation Reform Act , Lianne Applegarth ,
vimarsana.com © 2020. All Rights Reserved.